SUSQUEHANNA INTERNATIONAL GROUP, LLP - SAB BIOTHERAPEUTICS INC ownership

SAB BIOTHERAPEUTICS INC's ticker is and the CUSIP is 78397T103. A total of 28 filers reported holding SAB BIOTHERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of SAB BIOTHERAPEUTICS INC
ValueSharesWeighting
Q4 2022$6,749
-97.1%
11,441
-62.2%
0.00%
Q4 2021$236,00030,2340.00%
Other shareholders
SAB BIOTHERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
First PREMIER Bank 807,535$4760.14%
Warberg Asset Management LLC 370,370$218,5180.03%
METEORA CAPITAL, LLC 134,524$79,3560.02%
INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC 149,774$88,3520.02%
SILVER OAK SECURITIES, INCORPORATED 51,941$310.01%
Veritable, L.P. 506,513$298,7920.01%
Shaolin Capital Management LLC 236,621$1400.00%
Elgethun Capital Management 14,796$9,1710.00%
LGL PARTNERS, LLC 23,000$13,5680.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 84,000$49,5520.00%
View complete list of SAB BIOTHERAPEUTICS INC shareholders